Atlas Trials

Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia

Clinical trial NCT03304457 · COMPLETED

Trial details

NCT number
NCT03304457
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2017-08-25
Primary completion
2018-03-12
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.